The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature

Journal of Clinical Apheresis

Volumn 30, Issue 3, 2015, Pages 188-192

  Cook, Melissa K ^a   Malkin, Mark ^b   Karafin, Matthew S ^a,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Hashimoto's encephalopathy; Pheresis indications; Plasma exchange

Indexed keywords

ETIRACETAM; HARKOSERIDE; IMMUNOGLOBULIN; LEVOTHYROXINE; PHENOBARBITAL; PREDNISONE; STEROID; THYROID PEROXIDASE ANTIBODY; AUTOANTIBODY; IODIDE PEROXIDASE;

ADULT; AGGRESSION; ANTIBODY TITER; ARTICLE; CANCER STAGING; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FEMALE; FEVER; HASHIMOTO ENCEPHALOPATHY; HOSPITAL DISCHARGE; HUMAN; PARANOIA; PLASMAPHERESIS; REPEAT PROCEDURE; SEIZURE; THORAX RADIOGRAPHY; THYROID CARCINOMA; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; APHERESIS; BLOOD; COMPLICATION; ENCEPHALITIS; HASHIMOTO DISEASE; IMMUNOLOGY; MIDDLE AGED; PARANOID PSYCHOSIS; PLASMA EXCHANGE; PROCEDURES;

AUTOANTIBODIES; BLOOD COMPONENT REMOVAL; COGNITION DISORDERS; ENCEPHALITIS; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IODIDE PEROXIDASE; MIDDLE AGED; PARANOID DISORDERS; PLASMA EXCHANGE; PLASMAPHERESIS; STATUS EPILEPTICUS; STEROIDS;

EID: 84930867655     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21353     Document Type: Article

References (37)

1. Ferracci F, Bertiato G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004;217:165.
2. de Holanda NC, de Lima DD. Hashimoto's Encephalopathy: systematic review of the literature and an additional case. J Neuropsych Clin Neurosci 2011;23:384-390.
3. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-171.
4. Marshall GA, Doyle JJ. Long term treatment of Hashimoto's encephalopathy. J Neuropsychiatry Clin Neurosci 2006;18:14-20.
5. Liu CY, Tseng MC, Lin PH. Encephalopathy associated with autoimmune thyroid disease (Hashimoto's thyroiditis) presenting as depression: a case report. Gen Hosp Psychiatry 2011;33:641.e7-e9.
6. Lin ST, Chen CS, Yang P, Chen CC. Manic symptoms associated with Hashimoto's encephalopathy: response to corticosteroid treatment. J Neuropsychiatry Clin Neurosci 2011;23:E20-E21.
7. Gomez-Bernal GJ, Reboreda A, Romero F, Bernal MM, Gomez F. A case of Hashimoto's encephalopathy manifesting as psychosis. Prim Care Companion J Clin Psychiatry 2007;9:318-319.
8. Wilcox RA, To T, Koukourou A, Frasca J. Hashimoto's encephalopathy masquerading as acute psychosis. J Clin Neurosci 2008;15:1301-1304.
9. Mahmud FH, Lteif AN, Renaud DL, Reed AM, Brands CK. Steroid-responsive encephalopathy associated with Hashimoto's thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics 2003;112:686-690.
10. Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate. Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci 2013;331:67-71.
11. McGinley J, McCabe DJ, Fraser A, Casey E, Ryan T, Murphy R. Hashimoto's encephalopathy: an unusual cause of status epilepticus. Ir Med J 2000;93:118.
12. Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol 2012;69:14-20.
13. Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M. Hashimoto's encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 2007;78:196-197.
14. Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M. Hashimoto encephalopathy presenting with progressive cerebellar ataxia. BMJ Case Rep 2009.
15. Tang Y, Chu C, Lin MT, Wei G, Zhang X, Da Y, Huang H, Jia J. Hashimoto's encephalopathy mimicking spinocerebellar ataxia. J Neurol 2011;258:1705-1707.
16. Arya R, Anand V, Chansoria M. Hashimoto encephalopathy presenting as progressive myoclonus epilepsy syndrome. Eur J Paediatr Neurol 2013;17:102-104.
17. Gucuyener K, Serdaroglu A, Bideci A, Yazman Y, Soysal AS, Cinaz P. Tremor and myoclonus heralding Hashimoto's encephalopathy. J Pediatr Endocrinol Metab 2000;13:1137-1141.
18. McCabe DJ, Burke T, Connolly S, Hutchinson M. Amnestic syndrome with bilateral mesial temporal lobe involvement in Hashimoto's encephalopathy. Neurology 2000;54:737-739.
19. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 2007;21:799-811.
20. Nieuwenhuis L, Santens P, Vanwalleghem P, Boon P. Subacute Hashimoto's encephalopathy treated with plasmapheresis. Acta Neurol Belg 2004;104:80.
21. Boers PM, Colebatch JG. Hashimoto's encephalopathy responding to plasmapheresis. J Neurol Neurosurg Psychiatry 2001;70:132.
22. Bektas O, Yilmaz A. Hashimoto encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. Pediatr Neurol 2012;46:132-135.
23. Huang W, Xia C. Infectious disease or Hashimoto's encephalopathy flares: a case report. Seizure 2011;20:717-719.
24. Gul Mert G, Horoz OO. Hashimoto's encephalopathy: four cases and review of literature. Neuroscience 2014;124:302-306.
25. Nagpal T, Pande S. Hashimoto's encephalopathy: response to plasma exchange. Neurol India 2004;52:245.
26. Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005;64:165-166.
27. Jacob S, Rajabally YA. Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins. J Neurol Neurosurg Psychiatry 2005;76:455-456.
28. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966;2:512-514.
29. Ferracci F, Moretto G, Candeago RM, Cimini N, Conte F, Gentile M, Papa N, Carnevale A. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003;60:712-714.
30. Blanchin S, Coffin C, Viader F, Ruf J, Carayon P, Potier F, Portier E, Comby E, Allouche S, Ollivier Y, Reznik Y, Ballet JJ. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol 2007;192:13-20.
31. Moodley K, Botha J, Raidoo DM, Naidoo S. Immuno-localization of anti-thyroid antibodies in adult human cerebral cortex. J Neurol Sci 2011;302:114-117.
32. Fatourechi V. Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Pract Res Endocrinol Metab 2005;19:53-66.
33. Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy). Intern Emerg Med 2006;1:15-23.
34. Sawka AM, Fatourechi V, Boeve BF, Mokri B. Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996. Thyroid 2002;12:393-398.
35. Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W. Hashimoto encephalopathy: a brainstem vasculitis? Neurology 2000;54:769-770.
36. Drulović J, Andrejević S. Hashimoto's encephalopathy: a long-lasting remission induced by intravenous immunoglobulins. Vojnosanit Pregl 2011;68:452-454.
37. Fatemi S, Bedri J, Nicoloff JT. Encephalopathy associated with Hashimoto's thyroiditis: use of serum immunoglobulin G as a marker of disease activity. Thyroid 2003;13:227-228.